Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1681 1683
This examiner grants 71% of resolved cases
Cynthia B. Wilder is an examiner in Art Unit 1637 within Tech Center 1600. She has a track record of 916 resolved cases. Her allowance rate is 71.0 percent, showing that a strong majority of applications result in a patent grant. This 71.0 percent rate indicates a generally favorable environment for applicants seeking to navigate the examination process successfully.
The data reveals a significant interview lift of 26.6 percent for this examiner. This high lift value suggests that direct communication is an exceptionally effective tool for advancing applications and overcoming rejections. Practitioners should prioritize the 26.6 percent lift to improve their chances of success, as it represents a major advantage over standard written prosecution. The 916 resolved cases provide a reliable basis for this strategy.
The median time to allowance is 1096 days. This 1096-day timeframe serves as a useful guide for managing client expectations regarding the duration of the patent lifecycle. By combining the 71.0 percent allowance rate with the 1096-day median, attorneys can develop a comprehensive prosecution plan. These figures highlight the procedural tendencies within Art Unit 1637.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19552942 | USE OF 5-HYDROXYMETHYCYTOSINE OR 5-METHYLCYTOSINE FOR DISEASE DETECTION | Non-Final OA | Biomodal Limited |
| 17686083 | METHODS, COMPOSITIONS AND KITS FOR SMALL RNA CAPTURE, DETECTION AND QUANTIFICATION | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 18653257 | METHODS AND COMPOSITIONS FOR IN SITU DETECTION USING IMMOBILIZABLE PROBES | Non-Final OA | 10x Genomics, Inc. |
| 18282467 | METHODS AND MATERIALS FOR IDENTIFYING MYELOMA STAGE AND DRUG SENSITIVITY AND TREATING MYELOMA | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18468971 | Methods for Microbial Identification in Clinical Specimens by Differential Ribosomal RNA Probe Hybridization | Non-Final OA | The Regents of the University of California |
| 17941270 | EXTRACELLULAR REPETITIVE RNA BIOMARKERS OF MUTANT KRAS CANCERS | Non-Final OA | The Regents of the University of California |
| 18730361 | RESISTANCE AND VIRULENCE DIAGNOSTICS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18055024 | Multiplex End-Tagging Amplification of Nucleic Acids | Non-Final OA | President and Fellows of Harvard College |
| 18262519 | QUANTIFICATION OF CELLULAR PROTEINS USING BARCODED BINDING MOIETIES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18441809 | METHODS FOR SEQUENCING BIOPOLYMERS | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 18812056 | METHODS AND COMPOSITIONS FOR REDUCING NUCLEOTIDE IMPURITIES | Non-Final OA | Singular Genomics Systems, Inc. |
| 18688919 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | Non-Final OA | Becton, Dickinson and Company |
| 18418143 | ASSAY FOR DETECTING CLOSELY-RELATED SEROTYPES OF HUMAN PAPILLOMAVIRUS (HPV) | Non-Final OA | Becton, Dickinson and Company |
| 18339116 | METHODS AND SYSTEMS FOR ANALYZING METHYLATED POLYNUCLEOTIDES | Final Rejection | GUARDANT HEALTH, INC. |
| 18467510 | RNA PRINTING AND SEQUENCING DEVICES, METHODS, AND SYSTEMS | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18647340 | RADIOGENOMIC SIGNATURES IN BLADDER CANCER PATIENTS AND USES THEREOF | Non-Final OA | CEDARS-SINAI MEDICAL CENTER |
| 18836861 | NUCLEIC ACID DETECTION | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 17792812 | METHOD FOR SURVEYING ECOSYSTEM IN WATER ENVIRONMENT BY USING ENVIRONMENTAL RNA | Non-Final OA | Kao Corporation |
| 18760831 | Anodized Metal Oxide Substrates Supporting Solid Support Feature Arrays for Patterned Flowcells | Non-Final OA | Illumina, Inc. |
| 17618836 | METHODS FOR SEQUENCING POLYNUCLEOTIDES | Final Rejection | Illumina, Inc. |
| 18724405 | PRIMER PROBE FOR DETECTION, PRIMER PROBE SET, AND APPLICATION THEREOF | Non-Final OA | MACCURA BIOTECHNOLOGY CO., LTD. |
| 18267769 | PREPARATION OF NUCLEIC ACID SAMPLES FOR SEQUENCING | Non-Final OA | GRAIL, LLC |
| 18249131 | METHODS AND KITS FOR NUCLEIC ACID PURIFICATION | Final Rejection | PROTONDX LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy